Hemostemix Inc.
HMTXF
$0.05
$0.00-4.00%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 30.07% | 75.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -23.43% | -71.80% | |||
| Operating Income | 23.43% | 71.80% | |||
| Income Before Tax | 21.62% | 69.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 21.62% | 69.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 21.62% | 69.79% | |||
| EBIT | 23.43% | 71.80% | |||
| EBITDA | 23.43% | 71.79% | |||
| EPS Basic | 37.14% | 59.30% | |||
| Normalized Basic EPS | 44.00% | 61.54% | |||
| EPS Diluted | 37.14% | 59.30% | |||
| Normalized Diluted EPS | 44.00% | 61.54% | |||
| Average Basic Shares Outstanding | 25.43% | -24.96% | |||
| Average Diluted Shares Outstanding | 25.43% | -24.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||